The mammalian Ire1 inhibitor, 4?8C, exhibits broad anti-Aspergillus activity in vitro and in a treatment model of fungal keratitis.
The mammalian Ire1 inhibitor, 4?8C, exhibits broad anti-Aspergillus activity in vitro and in a treatment model of fungal keratitis. Front Cell Infect Microbiol. 2024; 14:1477463.